When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BNTX - Merck Stock Up On Molnupiravir But Don't Get Too Excited
BioNTech SE
Molnupiravir results are striking for very early treatment, but this doesn't compare with vaccination; the time window for effect is short and the trial was mostly with unvaccinated people.
Merck has a Phase 3 trial testing if molnupiravir can prevent infection of a person exposed to someone infected with COVID-19.
The commercial opportunities for COVID-19 remain primarily in the vaccine area; molnupiravir will have a role, but will it move the needle for Merck in the longer term?